AIDS-related Funding Opportunity Announcements (FOAs)
NIMH Notices of Funding Opportunities
Request for Applications (RFA)
RFA-MH-24-235: Biotypes of CNS Complications in People Living with HIV (P01 Clinical Trial Not Allowed)
RFA-MH-24-330: Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R01 Clinical Trial Optional)
RFA-MH-24-331: Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R21 Clinical Trial Optional)
RFA-MH-24-332: Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional)
Notice of Special Interest (NOSI)
NOT-MH-21-105: Notice of Special Interest (NOSI): Advancing Health Communication Research on HIV Prevention, Treatment and Cure
NOT-MH-22-095: Notice of Special Interest (NOSI): NIMH Priorities on Research on Aggression and Violence Against Others
NOT-MH-23-100: Notice of Data Sharing Policy for the National Institute of Mental Health
NOT-MH-23-200: Innovative Technologies to develop novel tools to prevent and treat HIV in underserved populations
NOT-MH-23-250: Notice of Special Interest (NOSI): Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults
NOT-MH-23-265: Notice of Special Interest (NOSI): Mental Health Comorbidities in HIV Prevention and Treatment
NOT-MH-23-270: Intersectional Stigma and Discrimination (ISD), or Other Social Determinants of Health (SSDOH) in HIV Prevention and Treatment
Program Announcement with Special Receipt, Referral, and/or Review Considerations (PAR)
PAR-20-307: Developmental AIDS Research Centers on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
PAR-20-308: NIMH AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
PAR-21-228: NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed)
PAR-23-061: Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Option)
PAR-23-062: Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Option)
Co-Sponsored Funding Opportunities
Notice of Special Interest (NOSI)
NOT-AI-21-054: Notice of Special Interest (NOSI): Harnessing Big Data to Halt HIV
NOT-AI-21-057: Notice of Special Interest (NOSI): HIV/AIDS in the Era of COVID-19: When Pandemics Collide
NOT-AI-22-072: Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation
NOT-DA-21-060: Notice of Special Interest (NOSI): Reducing Stigma Related to Drug Use in Human Service Settings
NOT-OD-21-100: Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health
Program Announcement with Special Receipt, Referral, and/or Review Considerations (PAR)
PAR-21-068: Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
PAR-21-297: Multipurpose Prevention Technology: Novel Systemic Options for Young Adults
PAR-22-248: HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
PAR-23-245: Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)